butions of Matsuda index, insulinogenic index, and disposition index were right-skewed, these indices were log-transformed. Differences of continuous variables between two groups were evaluated by the unpaired t test. Dichotomous variables and other discrete variables between two groups were compared by the Fisher's exact test and by the chi square test, respectively, except for the ordinal categories of fasting and 120-min glucose levels, which were compared by the Mann-Whitney's U test. We also performed logistic regression analysis to evaluate the association of obesity and visceral adiposity with decreased beta cell function. The decreased beta cell function was defined as the lowest quintile of disposition index in the whole study population. A p value less than 0.05 was considered to be significant. Statistical analyses were performed using IBM SPSS Statistics Version 19 (SPSS Inc.).
results Table 1 shows the clinical characteristics of the study population. The study population was 50 ± 9 years old and 1487 subjects (85%) were male. BMI was 22.7 ± 1.7 kg/m 2 in non-obese subjects and 27.5 ± 2.4 kg/m 2 in obese subjects. Compared to non-obese subjects, obese subjects were slightly but significantly younger (49 ± 10 years old vs. 51 ± 8 years old: p < 0.01) and more likely to have hyperglycemia and hyperinsulinemia (see Table 1 ).
They also had a significantly higher prevalence of hypertension and dyslipidemia (both p < 0.01). Fig. 1 shows the association of obesity with insulin sensitivity, insulin response, and beta cell function in each decile of 120-min glucose levels. The sample number and the fasting glucose levels in the subjects with and without obesity in each of the decile are shown in Table 2 . Fig. 1A shows insulin sensitivity assessed with Matsuda index in non-obese and obese subjects. In both of the subjects, increased 120-min glucose levels during 75-g OGTT were associated with decreased values of Matsuda index (Pearson's correlation coefficient r = -0.36, p < 0.01). When the index was compared between non-obese and obese subjects, obese subjects had significantly lower values of Matsuda index than non-obese subjects in every decile of 120-min glucose level (all p < 0.05). Fig. 1B shows insulin response assessed with insulinogenic index in non-obese and obese subjects. Increased 120-min glucose levels were associated with decreased values of insulinogenic index (r = -0.43, p < plasma glucose and insulin levels were measured at 0, 30, 60, and 120 min, from which indices of insulin sensitivity and insulin secretion were calculated. The assessment of glucose tolerance was in accordance with the report of World Health Organization (WHO) and International Diabetes Foundation (IDF), using 110 and 126 mg/dL of fasting glucose levels and 140 and 200 mg/dL of 120-min glucose levels as cutoff points [9] : diabetes mellitus (fasting glucose ≥ 126 mg/dL or 120-min glucose ≥ 126 mg/dL), impaired glucose tolerance (fasting glucose < 126 mg/dL and 120-min glucose ≥ 140 mg/dL and < 200 mg/dL), impaired fasting glucose (fasting glucose ≥ 110 mg/dL and < 126 mg/dL and 120-min glucose < 140 mg/dL), and normal glucose tolerance (fasting glucose < 110 mg/dL and 120min glucose < 140 mg/dL). We also used 100 mg/dL of fasting glucose levels as another cutoff point, since 100 to 109 mg/dL of fasting glucose levels were recently proposed as "high-normal" range [10] .
The primary outcome measure in the current study was pancreatic beta cell function evaluated with disposition index [11] . Insulin sensitivity was estimated with Matsuda index [12] , in which mean plasma glucose and insulin concentrations during OGTT were calculated by the trapezoid method. Insulin response was evaluated by insulinogenic index [13] , which was calculated as the ratio of the increase of insulin levels to that of glucose levels during the first 30 minutes of OGTT. Disposition index was calculated from the product of insulinogenic index and Matsuda index [11] .
The study population was divided into two groups according to body mass index (BMI): non-obese subjects (BMI < 25 kg/m 2 ) and obese subjects (BMI ≥ 25 kg/m 2 ) [14, 15] . We also evaluated visceral adiposity with waist circumference. Increased waist circumference was determined when their waist circumference was 85 cm or larger in males and 90 cm or larger in females [15, 16] .
To assess beta cell function in different degrees of glucose tolerance, we classified the study population into the deciles of 120-min glucose levels. Disposition index, as well as Matsuda index and insulinogenic index, in each decile was thereafter compared between the obese and non-obese subjects. The difference was also assessed between the subjects with and without increased waist circumference.
Data are given as means and standard deviations (SD) for continuous variables or as percentages for discrete variables, if not otherwise mentioned. Since the distri-are shown in Table 3 . There was no significant difference in disposition index between the subjects with and without increased waist circumference (all p > 0.05) ( Fig. 2C ). On the other hand, those with increased waist circumference had lower levels of Matsuda index and higher levels of insulinogenic index, although insulinogenic index in the highest decile exceptionally lost statistical significance (p = 0.15) ( Fig. 2A and B) .
We finally performed logistic regression analysis and investigated the association of obesity and increased waist circumference with decreased beta cell function ( Table 4 ). As shown in Table 4 , there was no significant association of obesity or increased waist circumference with decreased beta cell function. The similar findings were observed even when the subjects were limited to those with fasting glucose levels < 110 mg/ dL or < 100 mg/dL (Table 4 ). 0.01). In every decile of 120-min glucose levels, obese subjects had significantly higher values of insulinogenic index than non-obese subjects (all p < 0.05). Fig. 1C shows beta cell function assessed with disposition index in non-obese and obese subjects. In both subjects, 120-min glucose levels were negatively associated with the values of disposition index (r = -0.62, p < 0.01), as with the values of insulinogenic index. On the other hand, disposition index was not significantly different between non-obese and obese subjects in any decile of 120-min glucose levels (all p > 0.05), which was in contrast to insulinogenic index.
Similar findings were observed when the subjects were divided according to waist circumference (Fig.  2) . The sample number and the fasting glucose levels in the subjects with and without increased waist circumference in each decile of 120-min glucose levels (15) 0.08 Data are represented as mean ± standard deviation or number (percentage). The classification of glucose tolerance was in accordance with the report of WHO/IDF [9] . Data are n (percentage). Data are n (percentage). The current findings suggest that pancreatic beta cell function is similarly impaired in obese Japanese subjects compared to non-obese Japanese subjects with the same degree of glucose intolerance. The increased values of insulinogenic index observed in obese patients could be interpreted as a mere compensation of beta cells to insulin resistance. Some previous studies of other ethnicities also reported that there was no significant difference in beta cell function between obese and lean subjects [17] , although others did not always present consistent findings [18, 19] . However, in their analysis, BMI cutoff points for defining obesity were sometimes larger than 25 kg/m 2 (e.g., 27 and 30 kg/m 2 ), meaning that the lean groups included some overweight subjects with BMI ≥ 25 kg/m 2 and that obese subjects were not compared to those who were really "lean." Their results therefore might be affected by these study designs. Furthermore, previous studies seldom mentioned visceral adiposity, another key feature which could modify glucose metabolism [20] . It is now well known that visceral adiposity is commonly found even in subjects with lower BMI [15, 21] . Stratification by BMI alone might underestimate the influence of adiposity on pancreatic beta cell function. In addition, the difference of ethnicity might have some influence on the association of obesity with beta cell function [20, 22, 23] . It was therefore clinically important to assess the association of visceral adiposity, as well as obesity, with beta cell function in an ethnic group of interest.
The current study demonstrated that there was no significant difference in beta cell function between Japanese subjects with and without obesity or visceral adiposity. These findings suggest that a progressive decline of beta cell function is observed in the course of the development of glucose intolerance and finally diabetes mellitus, regardless of obesity and visceral adiposity, in a Japanese population. Future longitudinal studies will be needed to validate the current crosssectional findings.
The current study had some limitations. First, 75-g OGTT was performed in the health check-ups, rather than for a specified research purpose, and there were no predetermined criteria for undergoing 75-g OGTT. Consequently, the glucose tolerance of the study populations was widely distributed. However, this wide distribution in turn enabled us to assess the association between obesity and beta cell function, in the population with various degree of glucose tolerance.
Discussion
The current study revealed that disposition index derived from the data of 75-g OGTT was similarly decreased in obese Japanese subjects compared to nonobese Japanese subjects with the same post-load glucose levels. Similar findings were observed even after the stratification of the study population by waist circumference instead of BMI. These findings indicate that glucose intolerance is accompanied by a certain degree of pancreatic beta cell dysfunction in a Japanese population regardless of their obesity and visceral adiposity.
It has been well known that impaired beta cell function is a key pathogenesis for glucose intolerance, as decreased insulin sensitivity is [1, 2] . However, it remains obscure whether there is any difference in beta cell dysfunction between obese and lean Japanese subjects. It has been thought that obese patients are accompanied by insulin resistance, and accordingly, decreased insulin secretion might have a less impact on glucose intolerance in obese patients than in lean patients. To the best of our knowledge, this is the first report comparing pancreatic beta cell function between Japanese subjects with and without obesity or visceral adiposity who have the same degree of glucose tolerance.
In the current study, obesity, i.e., BMI ≥ 25 kg/m 2 , and visceral adiposity, i.e., waist circumference ≥ 85 cm in males and ≥ 90 cm in females, were associated with increased insulinogenic index ( Fig. 1B and Fig.  2B ), meaning that insulin was secreted in response to glucose increment more strongly in subjects with obesity and visceral adiposity. However, when disposition index was subsequently calculated, there was no significant difference between those with and without obesity or increased waist circumference (Fig. 1C and 2C) . The absence of significant difference was also confirmed by subsequent logistic regression analysis ( Table  4 ). On the other hand, insulin sensitivity, assessed with Matsuda index, was significantly impaired in the subjects with obesity or increased waist circumference ( Fig  1A and 2A) , as previously reported [8] .
It is well recognized that pancreatic beta cells respond to an increment in plasma glucose with an increment in plasma insulin, and this response is modulated by the degree of insulin sensitivity, with a hyperbolic relation [11] . Disposition index is based on this hyperbolic relation between insulin sensitivity and insulin secretion, and quantifies pancreatic beta cell function as the product of insulin sensitivity and insulin secretion [11] . uated with disposition index derived from the data of 75-g OGTT. Although 75-g OGTT has been widely used for the assessment of insulin secretion and insulin sensitivity both in clinical practice and in clinical studies [24] [25] [26] , the unified load of glucose regardless of clinical background might affect measurements and findings. Indeed, the relative dose of glucose load per body weight was different between lean and obese subjects. This difference might affect the current findings. Scientifically accurate assessment might be achieved when appropriate absolute doses of glucose is loaded on subjects in proportion to their body weight.
In conclusion, disposition index derived from the data of 75-g OGTT was similarly decreased in obese Japanese subjects compared to non-obese Japanese subjects with the same post-load glucose levels. Future studies will be needed to confirm whether the development of glucose intolerance in obese Japanese subjects is accompanied by the same degree of pancreatic beta cell dysfunction as non-obese Japanese subjects.
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Second, the definition of obesity and visceral adiposity in the current study was based on BMI and waist circumference, respectively. Although both of them are widely used for the assessment of adiposity in clinical and healthcare practice, they have limited accuracy, especially when compared to the assessment by computed tomography, for instance. Third, the current study had a high prevalence of male sex and a few females were included. However, given that the findings were unchanged after adjustment for sex as well as other variables (Table 2) , we believe the influence of sex on the findings would be small. Future studies with a sufficient number of females will be needed to validate the current findings. Fourth, a larger sample size might be needed, especially when respective analyses were performed in each decile of 120-min glucose levels. However, the current sample size could detect at least ~0.6 SD of differences with 80% of power in each of the decile. In addition, even when the study population was divided into quintiles to detect smaller differences (i.e., ~0.4 SD), observed findings were unchanged; there was no significant difference in disposition index, whereas Matsuda index was significantly lower and insulinogenic index was significantly higher in the subjects with obesity or abdominal adiposity (data not shown). Future studies with a larger sample size will be needed if the detection of a much smaller difference in each decile is required. Fifth and lastly, glucose tolerance was assessed by 75-g OGTT and pancreatic beta cell function was evalreferences
